Adiposity and risks of gastrointestinal cancers: A 10‐year prospective study of 0.5 million Chinese adults

Wing Ching Chan, Iona Y. Millwood, Christiana Kartsonaki, Huaidong Du, Daniel Schmidt, Rebecca Stevens, Junshi Chen, Pei Pei, Canqing Yu, Dianjianyi Sun, Jun Lv, Xianyong Han, Liming Li, Christopher Chen, Ling Yang, for the China Kadoorie Biobank (ckb) Collaborative GroupInternational Journal of Cancer 2024 · DOI

TL;DR

This large-scale prospective study in China reveals that while general adiposity (BMI, body fat) is linked to a lower risk of esophageal and stomach cancers, it's associated with a higher risk of colorectal cancer. Interestingly, fat-free mass shows a protective effect against esophageal cancer but a positive association with colorectal cancer, suggesting distinct biological pathways.

What Problem Does This Paper Address?

Gastrointestinal (GI) cancers, including esophageal (EC), stomach (SC), and colorectal (CRC), represent a significant global health burden, particularly in China. While obesity is a known risk factor for CRC, its relationship with EC and SC is less clear, especially in Asian populations where body composition differs from Westerners (e.g., higher body fat percentage at a given BMI). Furthermore, the roles of specific body composition components like fat-free mass and adiposity at different life stages (early adulthood vs. mid-life) remain underexplored. This study aims to clarify these complex associations by examining various adiposity measures in a large Chinese cohort.

Methods

The researchers utilized data from the prospective China Kadoorie Biobank (CKB) study, which enrolled over 500,000 adults aged 30-79. At baseline, participants underwent detailed physical measurements, including height, weight, body fat percentage (BF%), waist circumference (WC), and waist-to-hip ratio (WHR), using bioimpedance analysis and anthropometry. They also reported their weight at age 25. Over a median follow-up of 10.1 years, incident cases of EC, SC, and CRC were meticulously recorded.

The primary analytical approach involved Cox proportional hazards regression models. These models were used to estimate hazard ratios (HRs) for the association between different adiposity traits (both as continuous variables and in categories) and the risk of developing each type of GI cancer. The analyses were stratified by age and sex and adjusted for a comprehensive set of potential confounders, including study area, education, income, family history of cancer, smoking, alcohol consumption, physical activity, and dietary factors. To account for potential measurement error in adiposity, regression dilution ratios were applied to estimate HRs per standard deviation (SD) increase in "usual" adiposity. The study also employed mutual adjustment analyses to disentangle the independent effects of general (BMI, BF%, fat mass) and central (WC, WHR) adiposity, as well as fat mass and fat-free mass.

Datasets

The study used data from the China Kadoorie Biobank (CKB). This is a large, prospective cohort study involving 512,715 adults recruited between 2004 and 2008 from 10 areas in China. Baseline data included questionnaires and physical measurements. Follow-up data was collected through record linkage with national health insurance and disease registries, supplemented by active follow-up.

Key Insights and Ideas

  • Divergent Roles of Adiposity: The most striking finding is the opposing associations of general adiposity with different GI cancers. While excess body fat appears protective against EC and SC, it significantly increases CRC risk. This highlights that "adiposity" isn't a monolithic risk factor and its impact is cancer-specific.
  • Fat-Free Mass Matters: Beyond just fat, the amount of lean body mass (fat-free mass) also plays a role. It seems to offer some protection against EC, but paradoxically, it's linked to a higher risk of CRC. This suggests that metabolic processes related to muscle mass might influence cancer development differently depending on the GI site.
  • Central vs. General Adiposity: While general adiposity (overall body fat) showed consistent inverse associations with EC and SC, central adiposity (waist circumference) had a more robust positive association with CRC, even after accounting for general adiposity. This underscores the importance of abdominal fat distribution as a risk factor for CRC.
  • Early Adulthood Adiposity: Adiposity in early adulthood (BMI at age 25) was positively associated with all three cancer types, suggesting that early life body composition can have long-term implications for GI cancer risk, independent of later-life adiposity.
  • Subsite Heterogeneity: The study found differences in associations for stomach cancer subsites, with inverse associations for non-cardia SC but not for cardia SC. This points to distinct etiologies for these subtypes.

Key Results

  • Esophageal Cancer (EC): General adiposity (BMI, BF%, fat mass) was inversely associated with EC risk. For example, a 1 SD increase in BMI was associated with a 19% lower risk (HR 0.81). Fat-free mass showed a weak inverse association (HR 0.93 per SD). BMI at age 25 was positively associated with EC risk.
  • Stomach Cancer (SC): Similar to EC, general adiposity (BF%, WC) was inversely associated with SC risk (e.g., HR 0.79 for BF% per SD). Associations differed by subsite, with stronger inverse associations for non-cardia SC.
  • Colorectal Cancer (CRC): All adiposity traits examined (BF%, WC, fat mass, fat-free mass, BMI at age 25) were positively associated with CRC risk. For instance, a 1 SD increase in BF% was linked to a 9% higher risk (HR 1.09), and WC to a 17% higher risk (HR 1.17). Fat-free mass also showed a positive association (HR 1.09 per SD).
  • Mutual Adjustments: After mutual adjustment, general adiposity remained inversely associated with EC and SC, while central adiposity remained positively associated with CRC.

Limitations and Future Work

The authors acknowledge several limitations:

  • Residual Confounding: Despite extensive adjustments, residual confounding from unmeasured factors like diet, H. pylori infection, and other lifestyle habits cannot be entirely ruled out.
  • Reverse Causation: While sensitivity analyses excluding early years of follow-up were conducted, the long latency of cancer means that reverse causation (i.e., early cancer development influencing adiposity) cannot be fully excluded for the inverse associations observed with EC and SC.
  • Bioimpedance Accuracy: Body composition was measured using bioimpedance analysis, which is less precise than methods like DEXA. While validated, it can be influenced by hydration status.
  • Subtype Data: Histological subtype information was only available for a subset of EC cases, limiting the power for analyses restricted to confirmed ESCC.

Future research directions suggested include:

  • Diverse Populations: Further studies in populations with different adiposity patterns and GI cancer rates are needed to confirm these findings.
  • Mechanistic Studies: Investigating the biological mechanisms underlying the differential effects of fat mass, fat-free mass, and central adiposity on various GI cancer types is crucial.
  • Lifespan Adiposity: More research is needed to understand the long-term impact of adiposity across different life stages on cancer risk.

Summary updated

Abstract

Associations of adiposity with risks of oesophageal squamous cell carcinoma (ESCC) and non-cardia stomach cancer, both prevalent in China, are still inconclusive. While adiposity is an established risk factor for colorectal cancer, the relevance of fat-free mass and early-adulthood adiposity remains to be explored. The prospective China Kadoorie Biobank study included 0.5 million adults (aged 30-79 years) from 10 areas in China. Participants' body size and composition were measured at baseline and at resurveys (amongst a subset). After >10 years of follow-up, 2350, 3345 and 3059 incident cases of oesophageal (EC), stomach (SC) and colorectal (CRC) cancers were recorded, respectively. Cox regression was used to estimate hazard ratios (HRs) for these cancers in relation to different adiposity traits. General and central adiposity were inversely associated with EC (primarily ESCC) risk, with HRs of 0.81 (95% CI 0.77-0.85), 0.76 (0.72-0.81) and 0.87 (0.83-0.92) per SD increase in usual levels of BMI, body fat percentage (BF%) and waist circumference (WC), respectively. Adiposity was also inversely associated with SC risk [HR = 0.79 (0.75-0.83) and 0.88 (0.84-0.92) per SD increase in usual BF% and WC], with heterogeneity by cardia and non-cardia subsites, and positively associated with CRC [HR = 1.09 (1.03-1.15) and 1.17 (1.12-1.22) per SD higher usual BF% and WC]. Fat-free mass was inversely associated with EC [HR = 0.93 (0.89-0.98) per SD increase] but positively associated with CRC [1.09 (1.04-1.14)], while BMI at age 25 was positively associated with all three cancers. After mutual adjustment, general adiposity remained inversely associated with EC and SC, while central adiposity remained positively associated with CRC.
BibTeX
@article{chan2024adiposity,
  author = {Wing Ching Chan and Iona Y. Millwood and Christiana Kartsonaki and Huaidong Du and Daniel Schmidt and Rebecca Stevens and Junshi Chen and Pei Pei and Canqing Yu and Dianjianyi Sun and Jun Lv and Xianyong Han and Liming Li and Christopher Chen and Ling Yang and for the China Kadoorie Biobank (CKB) Collaborative Group},
  title = {{Adiposity and risks of gastrointestinal cancers: A 10‐year prospective study of 0.5 million Chinese adults}},
  journal = {International Journal of Cancer},
  year = {2024},
  doi = {10.1002/ijc.35303},
}
Figure